Global 10% Dextrose Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global 10% Dextrose Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Dextrose injection is a sterile solution used to provide your body with extra water and carbohydrates (calories from sugar). It is used when a patient is not able to drink enough liquids or when additional fluids are needed. 10% Dextrose Injection are indicated for use in adults and pediatric patients as sources of calories and water for hydration.
10% Dextrose Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 10% Dextrose Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from First-Aid Treatment and Sports are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 10% Dextrose Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, 10% Dextrose Injection key manufacturers include B. Braun Medical Inc, ICU Medical, Baxter, Fresenius Kabi, Pfizer, Alfa Laboratories, Drugfield Pharmaceuticals Limited, Otsuka Pharmaceutical and Schwitz Biotech, etc. B. Braun Medical Inc, ICU Medical, Baxter are top 3 players and held % sales share in total in 2022.
10% Dextrose Injection can be divided into 250 mL, 500 mL and 1000 mL,, etc. 250 mL is the mainstream product in the market, accounting for % sales share globally in 2022.
10% Dextrose Injection is widely used in various fields, such as First-Aid Treatment, Sports, Trophotherapy and Others, etc. First-Aid Treatment provides greatest supports to the 10% Dextrose Injection industry development. In 2022, global % sales of 10% Dextrose Injection went into First-Aid Treatment filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 10% Dextrose Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Pfizer
Alfa Laboratories
Drugfield Pharmaceuticals Limited
Otsuka Pharmaceutical
Schwitz Biotech
Segment by Type
250 mL
500 mL
1000 mL
First-Aid Treatment
Sports
Trophotherapy
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 10% Dextrose Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 10% Dextrose Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 10% Dextrose Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of 10% Dextrose Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 10% Dextrose Injection introduction, etc. 10% Dextrose Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 10% Dextrose Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
10% Dextrose Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 10% Dextrose Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from First-Aid Treatment and Sports are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 10% Dextrose Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, 10% Dextrose Injection key manufacturers include B. Braun Medical Inc, ICU Medical, Baxter, Fresenius Kabi, Pfizer, Alfa Laboratories, Drugfield Pharmaceuticals Limited, Otsuka Pharmaceutical and Schwitz Biotech, etc. B. Braun Medical Inc, ICU Medical, Baxter are top 3 players and held % sales share in total in 2022.
10% Dextrose Injection can be divided into 250 mL, 500 mL and 1000 mL,, etc. 250 mL is the mainstream product in the market, accounting for % sales share globally in 2022.
10% Dextrose Injection is widely used in various fields, such as First-Aid Treatment, Sports, Trophotherapy and Others, etc. First-Aid Treatment provides greatest supports to the 10% Dextrose Injection industry development. In 2022, global % sales of 10% Dextrose Injection went into First-Aid Treatment filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 10% Dextrose Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
B. Braun Medical Inc
ICU Medical
Baxter
Fresenius Kabi
Pfizer
Alfa Laboratories
Drugfield Pharmaceuticals Limited
Otsuka Pharmaceutical
Schwitz Biotech
Segment by Type
250 mL
500 mL
1000 mL
Segment by Application
First-Aid Treatment
Sports
Trophotherapy
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 10% Dextrose Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 10% Dextrose Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 10% Dextrose Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of 10% Dextrose Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 10% Dextrose Injection introduction, etc. 10% Dextrose Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 10% Dextrose Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.